These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31441862)

  • 1. Antiplatelet therapy and coronary artery bypass grafting: Protocol for a systematic review and network meta-analysis.
    Gupta S; Belley-Côté EP; Rochwerg B; Bozzo A; Panchal P; Pandey A; Mbuagbaw L; Mehta S; Schwalm JD; Whitlock RP
    Medicine (Baltimore); 2019 Aug; 98(34):e16880. PubMed ID: 31441862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet therapy and coronary artery bypass grafting: a systematic review and network meta-analysis.
    Gupta S; Belley-Cote EP; Panchal P; Pandey A; Basha A; Pallo L; Rochwerg B; Mehta S; Schwalm JD; Whitlock RP
    Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):354-363. PubMed ID: 32772110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy in patients receiving saphenous vein coronary artery bypass grafts: a protocol for a systematic review and network meta-analysis.
    Solo K; Martin J; Lavi S; Kabali C; John-Baptiste A; Nevis IF; Choudhury T; Mamas MA; Bagur R
    BMJ Open; 2018 Apr; 8(4):e019555. PubMed ID: 29627809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Meta-Analysis Comparing Aspirin Alone Versus Dual Antiplatelet Therapy for the Prevention of Venous Graft Failure Following Coronary Artery Bypass Surgery.
    Hesterberg K; Rawal A; Khan S; Rashid A; Jones D; Siddiqui T; Khader TA; Nayyar M; Shah R
    Cardiovasc Revasc Med; 2020 Jun; 21(6):792-796. PubMed ID: 31672535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network meta-analysis of antiplatelet therapy following coronary artery bypass grafting (CABG): none versus one versus two antiplatelet agents.
    Chakos A; Jbara D; Singh K; Yan TD; Tian DH
    Ann Cardiothorac Surg; 2018 Sep; 7(5):577-585. PubMed ID: 30505741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal antiplatelet strategy following coronary artery bypass grafting: a meta-analysis.
    Agrawal A; Kumar A; Majid M; Badwan O; Arockiam AD; El Dahdah J; Syed AB; Schleicher M; Reed GW; Cremer PC; Griffin BP; Menon V; Wang TKM
    Heart; 2024 Feb; 110(5):323-330. PubMed ID: 37648436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: An updated meta-analysis.
    Cardoso R; Knijnik L; Whelton SP; Rivera M; Gluckman TJ; Metkus TS; Blumenthal RS; McEvoy JW
    Int J Cardiol; 2018 Oct; 269():80-88. PubMed ID: 30072154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
    Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
    Contemp Clin Trials; 2018 May; 68():45-51. PubMed ID: 29551675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft Patency of a Second Conduit for Coronary Artery Bypass Surgery: A Network Meta-Analysis of Randomized Controlled Trials.
    Yokoyama Y; Takagi H; Kuno T
    Semin Thorac Cardiovasc Surg; 2022; 34(1):102-109. PubMed ID: 33609673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis.
    Sandner S; Redfors B; Angiolillo DJ; Audisio K; Fremes SE; Janssen PWA; Kulik A; Mehran R; Peper J; Ruel M; Saw J; Soletti GJ; Starovoytov A; Ten Berg JM; Willemsen LM; Zhao Q; Zhu Y; Gaudino M
    JAMA; 2022 Aug; 328(6):554-562. PubMed ID: 35943473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor for patients undergoing coronary artery bypass grafting: A meta-analysis of randomized controlled trials.
    Xiang F; Lin Y; Chen B
    Perfusion; 2023 May; 38(4):698-705. PubMed ID: 35403510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between dual antiplatelet treatment (DAPT) score and saphenous venous grafts patency after coronary artery bypass grafting surgery.
    Bayam E; Öztürkeri B; Yıldırım E; Kalçık M; Küp A; Çakmak EÖ; Günay N; Güner A; Kalkan S; Karaduman A; Kahyaoğlu M; Zehir R
    Acta Cardiol; 2021 Sep; 76(7):785-791. PubMed ID: 33880976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial.
    Willemsen LM; Janssen PWA; Hackeng CM; Kelder JC; Tijssen JGP; van Straten AHM; Soliman-Hamad MA; Deneer VHM; Daeter EJ; Sonker U; Klein P; Ten Berg JM
    Am Heart J; 2020 Feb; 220():237-245. PubMed ID: 31884246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
    Zhao Q; Zhu Y; Xu Z; Cheng Z; Mei J; Chen X; Wang X
    JAMA; 2018 Apr; 319(16):1677-1686. PubMed ID: 29710164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel endothelial damage inhibitor for the treatment of vascular conduits in coronary artery bypass grafting: protocol and rationale for the European, multicentre, prospective, observational DuraGraft registry.
    Caliskan E; Sandner S; Misfeld M; Aramendi J; Salzberg SP; Choi YH; Satishchandran V; Iyer G; Perrault LP; Böning A; Emmert MY
    J Cardiothorac Surg; 2019 Oct; 14(1):174. PubMed ID: 31615560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prehospitalization antiplatelet therapy and outcomes after saphenous vein graft intervention.
    Harskamp RE; Beijk MA; Damman P; Tijssen JG; Lopes RD; de Winter RJ
    Am J Cardiol; 2013 Jan; 111(2):153-8. PubMed ID: 23102882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis.
    Solo K; Lavi S; Kabali C; Levine GN; Kulik A; John-Baptiste AA; Fremes SE; Martin J; Eikelboom JW; Ruel M; Huitema AA; Choudhury T; Bhatt DL; Tzemos N; Mamas MA; Bagur R
    BMJ; 2019 Oct; 367():l5476. PubMed ID: 31601578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial.
    Willemsen LM; Janssen PWA; Peper J; Soliman-Hamad MA; van Straten AHM; Klein P; Hackeng CM; Sonker U; Bekker MWA; von Birgelen C; Brouwer MA; van der Harst P; Vlot EA; Deneer VHM; Chan Pin Yin DRPP; Gimbel ME; Beukema KF; Daeter EJ; Kelder JC; Tijssen JGP; Rensing BJWM; van Es HW; Swaans MJ; Ten Berg JM
    Circulation; 2020 Nov; 142(19):1799-1807. PubMed ID: 32862716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
    Gao G; Zheng Z; Pi Y; Lu B; Lu J; Hu S
    J Am Coll Cardiol; 2010 Nov; 56(20):1639-43. PubMed ID: 21050973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery.
    Gluckman TJ; McLean RC; Schulman SP; Kickler TS; Shapiro EP; Conte JV; McNicholas KW; Segal JB; Rade JJ
    J Am Coll Cardiol; 2011 Mar; 57(9):1069-77. PubMed ID: 21349398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.